Developing minimally invasive, high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders. Project aim and objective The current diagnosis of schizophrenia involves examination and monitoring by psychiatrists, a process which can ta
Recent Comments